MONTE ROSA THERAPEUTICS INC (GLUE) Stock News
USA - NASDAQ:GLUE - US61225M1027 - Common Stock
14.36 USD
+0.04 (+0.28%)
14.36 USD
0 (0%)
GLUE Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Chartmill
9 days ago - By: Monte Rosa Therapeutics, Inc.
11 days ago - By: Zacks Investment Research - Mentions: MIRM
12 days ago - By: Monte Rosa Therapeutics, Inc.
12 days ago - By: Monte Rosa Therapeutics, Inc.
22 days ago - By: Monte Rosa Therapeutics, Inc.
22 days ago - By: Monte Rosa Therapeutics, Inc.
2 months ago - By: Stocktwits - Mentions: NVS
2 months ago - By: Monte Rosa Therapeutics, Inc.
2 months ago - By: Monte Rosa Therapeutics, Inc.
2 months ago - By: Monte Rosa Therapeutics, Inc.
2 months ago - By: Monte Rosa Therapeutics, Inc.
3 months ago - By: The Motley Fool - Mentions: NVS
3 months ago - By: Zacks Investment Research - Mentions: IRD
3 months ago - By: Monte Rosa Therapeutics, Inc.
3 months ago - By: Monte Rosa Therapeutics, Inc.
3 months ago - By: Zacks Investment Research - Mentions: CERT
4 months ago - By: Monte Rosa Therapeutics, Inc.
4 months ago - By: Monte Rosa Therapeutics, Inc.
4 months ago - By: Monte Rosa Therapeutics, Inc.
4 months ago - By: Monte Rosa Therapeutics, Inc.
5 months ago - By: Monte Rosa Therapeutics, Inc.
5 months ago - By: Monte Rosa Therapeutics, Inc.
6 months ago - By: Monte Rosa Therapeutics, Inc.
6 months ago - By: Zacks Investment Research - Mentions: IGMS
